Related Experiment Video
Updated: Jun 4, 2026
03:42
Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture
Published on: September 27, 2024
TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression.
M Seux1, S Peuget, M P Montero
1INSERM, U624 Stress cellulaire, Marseille, France.
Oncogene
|February 23, 2011
Summary
Tumor protein 53 induced nuclear protein 1 (TP53INP1) suppresses pancreatic cancer by reducing cell migration. Loss of TP53INP1 increases migration through upregulation of SPARC, a key factor in tumor spread.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- TP53INP1 is a p53 target gene crucial for oxidative stress response and tumor suppression.
- TP53INP1 is downregulated in early pancreatic cancer and its restoration inhibits tumor development.
- TP53INP1 downregulation is linked to oncogenic miR-155 in pancreatic cancer.
Purpose of the Study:
- To investigate the role of TP53INP1 in regulating cell migration in pancreatic cancer.
- To identify the molecular mechanisms by which TP53INP1 influences cell migration.
- To explore the therapeutic potential of targeting TP53INP1 in pancreatic adenocarcinoma.
Main Methods:
- Studied TP53INP1 effects on cell migration in mouse embryonic fibroblasts and pancreatic cancer cell lines.
- Assessed cell migration in vivo and in vitro.
- Analyzed the transcriptional regulation of SPARC by TP53INP1.
Main Results:
- TP53INP1 inactivation correlated with increased cell migration both in vivo and in vitro.
- TP53INP1 expression decreased cell migration by transcriptionally downregulating SPARC.
- SPARC was upregulated in TP53INP1-deficient pancreatic lesions in a mouse model.
Conclusions:
- TP53INP1 acts as a tumor suppressor in pancreatic adenocarcinoma by inhibiting cell migration.
- TP53INP1 regulates cell migration via transcriptional downregulation of SPARC.
- Modulating TP53INP1-SPARC axis may offer a novel therapeutic strategy for pancreatic cancer.
